Navigation Links
Traffic Smoke May Damage DNA,,,,

In a study conducted by Department of Public Health, National Defense Medical Center, of Taiwan, scientists have found // that the traffic fumes inhaled during working at a toll station can damage the DNA of the persons inhaling the fumes.

The research studied 47 female highway toll station workers who were exposed to traffic fumes versus workers of an office setting. Using average and cumulative traffic density and a biomarker of exposure, the researchers found out workers being affected by oxidative DNA damage. They also measured plasma nitric oxide as an indicator to oxidative stress due to traffic exhaust exposure. The stress level was also high in these workers of the toll stations.

During the lifetime of a human being DNA receives potentially damage causing biological and chemical toxins from the environment. This may lead to cellular death or some other forms of distress like cancer and other diseases. Current DNA studies focus on the structure and the function of the DNA of the cells to understand the processes and suggest ways to control the damage.

The ability to control DNA damage varies from person to person and how to go about it may need extensive study regarding the genetic and nutritional information of the patients.
'"/>




Page: 1

Related medicine news :

1. Traffic pollution linked to severe asthma attacks
2. Traffic Violations Result in Safer Drivers
3. HIV Infection Higher In Drug Trafficking Countries
4. Alcohol And Drug Abuse (Cannabis) Leading Causes For Road Traffic Accidents
5. Trafficking of Women from Asia and East Europe For Flesh Trade
6. Travel And Tourism Industry Calls For Global Efforts To Limit Sexual Trafficking Of Children
7. Asthma Risk Pronounced In Children Living Close to Traffic Ridden Roads
8. Striking Doctors Form Human Chain, Block Traffic
9. Road Traffic Accidents Kill 4,000 people in Delhi
10. Illegal Drug Trafficking Pose A Great Threat For HIV Epidemic In Northeast
11. India & Singapore Join hands to Fight Terror & Drug Trafficking
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... Launching ... innovative Unified Instance Manager architecture, meeting the needs of multichannel growth and ... the unattended auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased to announce that ... for Texas, they are expanding their presence in Dallas. One of the most exciting ... bring new jobs to the Dallas and Forth Worth market. STAT takes pride in ...
(Date:12/8/2016)... ... December 08, 2016 , ... Healthcare is ... Dr. Botelho advocates for the mass media launching of story movements to highlight ... to share their unfortunate experiences; such a movement can generate the network power ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016 Australia Glaucoma Surgery ... GlobalData,s new report, "Australia Glaucoma Surgery Devices Market ... the Australia Glaucoma Surgery Devices market. The report ... (in units) and average prices (USD) within market ... also provides company shares and distribution shares data ...
(Date:12/8/2016)... KEY FINDINGS The global medical lifting sling ... for growth of the medical lifting sling market are ... high recovery cost of injuries and government initiatives to ... refers to an assistive device that helps caregiver transfer ... the lift and hold the patient. It is important ...
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
Breaking Medicine Technology: